personalized semaglutide Weight Loss – Verge Hims & Hers Expands Personalized

Arch Cardiovasc Dis

Obesity Semaglutide has been approved for weight management in individuals with a BMI of 30 or higher or those with a BMI of 27 or higher with at least one weight-related condition, such as hypertension or dyslipidemia

However, regular liver function monitoring is recommended during treatment

Fat burning and weight loss are challenging and as long as we are making the appropriate dietary and lifestyle changes, we should also ensure an adequate supply of those nutrients required for optimum fat metabolism

12 Due to these potential side effects, medical supervision is crucial when initiating and maintaining treatment with semaglutide